Sichuan Good Doctor Panxi Pharmaceutical describes new wound-healing polypeptides March 17, 2022 No Comments
VYN-201 reduces key inflammatory biomarkers involved in vitiligo pathogenesis in preclinical model March 7, 2022 No Comments
NTLA-2002 shows promising preclinical results in a partial hepatectomy-induced HAE model March 3, 2022 No Comments
Targeting MRGPRX2-mediated mast cell activation as a therapeutic strategy for atopic dermatitis March 1, 2022 No Comments
Repertoire Immune Medicines and UMass Chan collaborate to understand immune causes of vitiligo Feb. 18, 2022 No Comments
Financing at Third Harmonic Bio to support development of oral KIT inhibitor THB-001 Feb. 16, 2022 No Comments
Almirall signs agreements with Ablexis and AliviaMab to support work in dermatology Feb. 1, 2022 No Comments
Almirall and IRB Barcelona collaborate on molecular glue degraders for skin diseases Jan. 19, 2022 No Comments